Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization

Abroad (travel likely)RecruitingPHASE1

Conditions

Melanoma · Soft Tissue Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Florida, Gainesville, Florida, United States
Contact: Study coordinator (Brittany Lansford) · bpolo6962@ufl.edu · 352-273-5045
Contact: Principal Investigator (Leighton Elliott, MD)

Study leads

Leighton Elliott, MD
Principal Investigator
University of Florida

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Using QPOP to Predict Treatment for Sarcomas and Melanomas

Sarcoma · Melanoma

Abroad (travel likely)Recruiting

Singapore, Singapore

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Head and Neck Cancer · Cervical Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jinan, China

A Study of BI 3810944 in Patients With Advanced Cancer

Solid Tumours · Melanoma

Abroad (travel likely)RecruitingPHASE1

Louisville, United States · Nashville, United States

A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies

Non-Small Cell Lung Cancer, Colorectal Cancer, Renal Cell Carcinoma, Melanoma and Other Solid Tumor

Abroad (travel likely)RecruitingPHASE1

Fuzhou, China · Guangzhou, China